After 12 weeks of an HFD treatment, the obese insulin-resistant rat model was successfully developed, as evidenced by the significant gain in body weight, elevated plasma insulin and HOMA- IR index, hyperglycemia, and impaired glucose tolerance, which are known to exacerbate the progression of type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.